Pharma news
Africa
Pharmaceutical company GSK has adopted a new approach to patents and intellectual property to widen access to medicines in the world’s poorest countries. 1 April 2016
Pharma
Owners of second medical use patents may need to think outside the box in terms of the relief they seek for infringement, says Katie Hutchinson of Bristows. 31 March 2016
Asia
India-based pharmaceutical company Sun Pharmaceutical has acquired 14 prescription brands from Novartis in Japan for $293 million. 31 March 2016
Americas
US presidential hopeful Bernie Sanders has urged the government to hold a hearing to determine whether a patent covering a prostate cancer drug should be licensed in a bid to lower its price. 30 March 2016
Americas
Biopharmaceutical company Shire has had a patent for Lialda upheld in its trial against Watson Pharmaceuticals. 30 March 2016
Americas
Gilead has been ordered to pay Merck $200 million in damages following a trial that found it had infringed patents covering hepatitis C treatments. 29 March 2016
Pharma
The UK Supreme Court has said it will hear a patent dispute between Eli Lilly and Allergan centring on cancer drug Alimta. 24 March 2016
Pharma
Despite a large body of EPO case law accepting second medical use claims that recite a novel technical effect, all eyes are on how courts in EPC member states will deal with infringement cases arising from such patents. Joachim Wachenfeld and Oswin Ridderbusch of Vossius & Partner report. 24 March 2016
Americas
Pharmaceutical company Teva has launched a generic version of Merck’s Campral drug in the US. 23 March 2016
Americas
A US court has upheld the validity of two patents owned by Merck in the pharmaceutical company’s dispute with drug maker Gilead centring on hepatitis C treatments. 23 March 2016